Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
No of Months
12
12
Operating Income
7.00
7.00
Less :Inter divisional transfers
0.00
0.00
Less: Excise
0.00
0.00
Net Sales
7.00
7.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
Raw Materials Consumed
3.00
3.00
Power & Fuel Cost
0.00
0.00
Employee Cost
1.00
1.00
Operating Expenses
0.00
0.00
General and Administration Expenses
-1.00
-1.00
Selling and Distribution Expenses
0.00
0.00
Cost of Software developments
0.00
0.00
Miscellaneous Expenses
0.00
2.00
Expenses Capitalised
0.00
0.00
Total Expenditure
8.00
9.00
Operating Profit (PBDIT) excl Other Income
-1.00
-2.00
Other Income
0.00
0.00
Operating Profit (PBDIT)
-1.00
-1.00
Interest
0.00
0.00
Profit before Depriciation and Tax
-1.00
-1.00
Depreciation
0.00
0.00
Profit Before Taxation & Exceptional Items
-1.00
-2.00
Exceptional Income / Expenses
0.00
0.00
Profit Before Tax
-1.00
-2.00
Provision for Tax
0.00
0.00
Profit After Tax
-1.00
-2.00
Extraordinary Items
0.00
0.00
Adj to Profit After Tax
0.00
0.00
Profit Balance B/F
-3.00
-1.00
Profit Available for appropriations
-4.00
-3.00
Appropriations
-4.00
-3.00
Equity Dividend (%)
0.00%
0.00%
Earnings Per Share
-6.70
-14.18
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 0.65% vs NA in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 34.69% vs NA in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 74.38% vs NA in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 52.86% vs NA in Mar 2025
Compare Profit and Loss Results of Skybiotech Healt
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
7.00
0
7.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
7.00
0
7.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
3.00
0
3.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
1.00
0
1.00
0%
Operating Expenses
0.00
0
0.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
8.00
0
8.00
0%
Operating Profit (PBDIT) excl Other Income
-1.00
0.00
-1.00
0%
Other Income
0.00
0
0.00
0%
Operating Profit (PBDIT)
-1.00
0
-1.00
0%
Interest
0.00
0
0.00
0%
Profit before Depriciation and Tax
-1.00
0
-1.00
0%
Depreciation
0.00
0
0.00
0%
Profit Before Taxation & Exceptional Items
-1.00
0
-1.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
-1.00
0
-1.00
0%
Provision for Tax
0.00
0
0.00
0%
Profit After Tax
-1.00
0
-1.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
-3.00
0
-3.00
0%
Profit Available for appropriations
-4.00
0
-4.00
0%
Appropriations
-4.00
0
-4.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-6.7
0
-6.70
0%
Profit And Loss - Net Sales
Net Sales 7.10 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.65% vs NA in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.47 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 34.69% vs NA in Mar 2025
Profit And Loss - Interest
Interest 0.02 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 74.38% vs NA in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax -1.12 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 52.86% vs NA in Mar 2025
